Direct-Acting Antivirals and Risk of Hepatocellular Carcinoma in People With HIV/HCV Coinfection

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Denver, Colorado
March 3-6 2024


Direct-Acting Antivirals and Risk of Hepatocellular Carcinoma in People With HIV/HCV Coinfection

	CROI 2024 March 3-6 Denver Daniela K van Santen1, on behalf of the HepCAUSAL Collaboration CAUSALab, Harvard T.H. Chan School of Public Health1